September 7, 2018 – Dr Rozakis

xR’s Emerging New Therapy to Treat Wet Macular Degeneration Non-Invasively Showing Unprecedented Results

Macular degeneration, a chronic and progressive disease, affects an estimated 12 million Americans and this number is expected to rise to 22 million. 10% currently have the wet form of…

1 Comment

September 7, 2018

Read more about the article xR’s Emerging New Therapy to Treat Wet Macular Degeneration Non-Invasively Showing Unprecedented Results

Press Releases

Beyond AREDS2: Vision Improvement in Macular Degeneration using Hormones, Genetics, Methylation, Nutrition and Anti-Oxidative Therapy

Ophthalmologist George Rozakis MD reviews why the recently completed AREDS2 study failed to provide incremental improvement in macular degeneration therapy and reviews a case history of a patient whose vision…

1 Comment

September 7, 2018

Read more about the article Beyond AREDS2: Vision Improvement in Macular Degeneration using Hormones, Genetics, Methylation, Nutrition and Anti-Oxidative Therapy

Press Releases

The Human Genome Project has Delivered on its Promise to Treat Disease. Introducing GEMS, the Genetic Enzyme Methylation Syndrome

According to xR, the 4 billion dollar human genome study has provided data that will benefit the diagnosis and therapy of a great number of chronic diseases such as ADHD,…

Comments Off

September 7, 2018

+1 440-777-2667